Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FHXMY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,584
Award facts
- Contract value 100% obligated
- $32,583.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,583.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.999 billion and extending through December 2026.
Zepbound is a GLP-1 receptor agonist medication indicated for chronic weight management in eligible patients. This delivery order represents a routine pharmaceutical supply transaction supporting the Defense Health Agency's medical supply chain requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with DLA covering diverse pharmaceutical products and medical supplies essential to military and veteran healthcare systems. The company's extensive experience fulfilling federal procurement requirements through competitive awards demonstrates its capability to support the Department of Defense's pharmaceutical needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FHXMY?
SPE2DB25FHXMY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FHXMY worth?
The government has obligated $32,584 on SPE2DB25FHXMY.
Is contract SPE2DB25FHXMY an order under another contract?
Yes. SPE2DB25FHXMY is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB25FHXMY competed?
The extent of competition for SPE2DB25FHXMY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award